BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16876675)

  • 1. Prevalence of uncontrolled hypertension in patients with Fabry disease.
    Kleinert J; Dehout F; Schwarting A; de Lorenzo AG; Ricci R; Kampmann C; Beck M; Ramaswami U; Linhart A; Gal A; Houge G; Widmer U; Mehta A; Sunder-Plassmann G
    Am J Hypertens; 2006 Aug; 19(8):782-7. PubMed ID: 16876675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study).
    Van der Niepen P; Woestenburg A; Brié H; Vancayzeele S; MacDonald K; Denhaerynck K; Lee C; Hermans C; Abraham I
    Ann Pharmacother; 2009 May; 43(5):849-61. PubMed ID: 19351876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stepwise increase in the prevalence of isolated systolic hypertension with the stages of chronic kidney disease.
    Cheng LT; Gao YL; Gu Y; Zhang L; Bi SH; Tang W; Wang T
    Nephrol Dial Transplant; 2008 Dec; 23(12):3895-900. PubMed ID: 18632588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH; Burgess ED; Assouline L; Vanjaka A
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of blood pressure and prevalence of hypertension in Tehran adult population: Tehran Lipid and Glucose Study (TLGS), 1999-2000.
    Azizi F; Ghanbarian A; Madjid M; Rahmani M
    J Hum Hypertens; 2002 May; 16(5):305-12. PubMed ID: 12082490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway.
    Munkhaugen J; Lydersen S; Widerøe TE; Hallan S
    Am J Kidney Dis; 2009 Oct; 54(4):638-46. PubMed ID: 19515474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialysis and transplantation in Fabry disease: indications for enzyme replacement therapy.
    Mignani R; Feriozzi S; Schaefer RM; Breunig F; Oliveira JP; Ruggenenti P; Sunder-Plassmann G
    Clin J Am Soc Nephrol; 2010 Feb; 5(2):379-85. PubMed ID: 20056752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure control in patients initiating antihypertensive therapy.
    Weycker D; Edelsberg J; Vincze G; Levy DG; Kartashov A; Oster G
    Ann Pharmacother; 2008 Feb; 42(2):169-76. PubMed ID: 18182472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease.
    Ho PM; Magid DJ; Shetterly SM; Olson KL; Peterson PN; Masoudi FA; Rumsfeld JS
    Arch Intern Med; 2008 Feb; 168(3):271-6. PubMed ID: 18268167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels and trends in blood pressure and prevalence and treatment of hypertension in The Netherlands, 1987-1991.
    van Leer EM; Seidell JC; Kromhout D
    Am J Prev Med; 1994; 10(4):194-9. PubMed ID: 7803060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications: a sub-analysis of the CASE-J trial.
    Ogihara T; Saruta T; Rakugi H; Fujimoto A; Ueshima K; Yasuno S; Oba K; Takeda K; Higaki J; Nakao K;
    Hypertens Res; 2009 Apr; 32(4):248-54. PubMed ID: 19347033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive efficacy of indapamide SR in hypertensive patients uncontrolled with a background therapy: the NATIVE study.
    Akram J; Sheikh UE; Mahmood M; Donnelly R
    Curr Med Res Opin; 2007 Dec; 23(12):2929-36. PubMed ID: 17931463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure control among Indians with hypertension: the I-Target survey.
    Hathial M
    J Indian Med Assoc; 2007 Jul; 105(7):401-2, 404, 410. PubMed ID: 18178998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and determinants of hypertension in chronic hemodialysis patients in Japan.
    Iseki K; Nakai S; Shinzato T; Morita O; Shinoda T; Kikuchi K; Wada A; Kimata N; Akiba T
    Ther Apher Dial; 2007 Jun; 11(3):183-8. PubMed ID: 17497999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure, proteinuria and nephropathy in Fabry disease.
    Jain G; Warnock DG
    Nephron Clin Pract; 2011; 118(1):c43-8. PubMed ID: 21071972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy.
    Ortiz A; Oliveira JP; Waldek S; Warnock DG; Cianciaruso B; Wanner C;
    Nephrol Dial Transplant; 2008 May; 23(5):1600-7. PubMed ID: 18175781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hypertension in the United States.
    Ezzati M; Oza S; Danaei G; Murray CJ
    Circulation; 2008 Feb; 117(7):905-14. PubMed ID: 18268146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
    Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regular alcohol drinking is a determinant of masked morning hypertension detected by home blood pressure monitoring in medicated hypertensive patients with well-controlled clinic blood pressure: the Jichi Morning Hypertension Research (J-MORE) study.
    Ishikawa J; Kario K; Eguchi K; Morinari M; Hoshide S; Ishikawa S; Shimada K;
    Hypertens Res; 2006 Sep; 29(9):679-86. PubMed ID: 17249523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.